News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Akhil Santhosh: First-Line Adagrasib and Pembrolizumab for Metastatic NSCLC
Akhil Santhosh
Apr 13, 2025, 18:24

Akhil Santhosh: First-Line Adagrasib and Pembrolizumab for Metastatic NSCLC

Akhil Santhosh,  Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:

“First line adagrasib + pembrolizumab for metastatic NSCLC with PDL1>50% and KRAS G12 C: Krystal 7 phase 2 study”

Adagrasib

More posts featuring Akhil Santhosh.

Adagrasib cancer Lung cancer NSCLC OncoDaily Oncology pembrolizumab
Special Coverage
Blog
Aug 5, 2025, 15:57
Fabio Ynoe de Moraes: Radiotherapy Can "Heat Up" Cold Lung Tumors and Boost Immunotherapy Responses
Blog
Aug 5, 2025, 15:32
Sumanta Pal: Our Terrific Surgeons are Blazing New Trails for Challenging to Treat Diseases
Opinion
Aug 5, 2025, 15:01
Timothy Winschel: Excited to Share Our Recent Paper Published in Supportive Care in Cancer
Career
Aug 5, 2025, 14:16
Julie Gralow Received the 2025 NCG Lifetime Achievement Award in Oncology
Blog
Aug 5, 2025, 13:23
Can Exercise Change Cancer Care?
Immune Oncology
Aug 5, 2025, 13:09
FDA Fast Track for CLD-201: Stem Cell–Based Oncolytic Virus for Soft Tissue Sarcoma
Insight
Aug 5, 2025, 12:52
Chris Boshoff: Pfizer’s Updates from the Second Quarter
Blog
Aug 5, 2025, 12:52
Davit Zohrabyan: Thanks to The Max Foundation for Giving Patients a Chance to Cancer Treatment
Insight
Aug 5, 2025, 12:39
Lorlatinib as First Treatment for ALK+ Lung Cancer - ALK Positive Inc.
Blog
Aug 5, 2025, 12:38
Ryan Nipp: Symptom Severity During Cancer Treatment Using the Symptom Care at Home Digital Platform
Career
Aug 5, 2025, 12:29
Nerses Shahbazyan: Happy to Share that I Took Part in the ESMO Course for Medical Students in Valencia
Blog
Aug 5, 2025, 12:12
What Does the Tumor-Infiltrating Lymphocyte (TIL) Therapy Process Look Like - City of Hope